Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment

about

Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment

Item

http://www.wikidata.org/entity/Q57300017

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment

@en

Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment

@nl

type

Item

label

Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment

@en

Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment

@nl

prefLabel

Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment

@en

Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment

@nl

P1476

Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment

@en

P2093

Amanda Rosewell Shaw

http://www.w3.org/2001/XMLSchema#string

Masataka Suzuki

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Chimeric antigen receptor T cells for sustained remissions in leukemia

A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes.

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.

Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors.

Adenovirus Improves the Efficacy of Adoptive T-cell Therapy by Recruiting Immune Cells to and Promoting Their Activity at the Tumor.

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

Combination cancer immunotherapy and new immunomodulatory targets.

Immune surveillance of tumors.

Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma

P304

2103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.3389/FIMMU.2018.02103

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2018-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30298067

http://www.w3.org/2001/XMLSchema#string

P921

intracellular receptor

oncolytic virus

membrane proteins

Añaw

P932

6160535

http://www.w3.org/2001/XMLSchema#string